2016
DOI: 10.2147/jpr.s123454
|View full text |Cite
|
Sign up to set email alerts
|

An investigation of completion times on the Screener and Opioid Assessment for Patients with Pain – revised (SOAPP-R)

Abstract: BackgroundRespondents’ scores to the Screener and Opioid Assessment for Patients with Pain – revised (SOAPP-R) have been shown to be predictive of aberrant drug-related behavior (ADB). However, research is lacking on whether an individual’s completion time (the amount of time that he/she takes to finish the screener) has utility in predicting ADB, despite the fact that response speed has been useful in predicting behavior in other fields. The purpose of this study was to evaluate the degree to which SOAPP-R co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 47 publications
0
5
2
Order By: Relevance
“…This is in contrast with published studies describing the specificity of the SOAPP ® -R 52%, [35] and the sensitivities of the SOAPP ranging from 72% to 80% [35,36] and the ORT 45% [36]. The published AUC of the SOAPP-R ranges from 0.67-0.76, [37] which are lower than the AUC of the profile, in all cases except one. Analyzing rating patterns sheds light on how physicians use and appreciate the profile.…”
Section: Discussioncontrasting
confidence: 75%
“…This is in contrast with published studies describing the specificity of the SOAPP ® -R 52%, [35] and the sensitivities of the SOAPP ranging from 72% to 80% [35,36] and the ORT 45% [36]. The published AUC of the SOAPP-R ranges from 0.67-0.76, [37] which are lower than the AUC of the profile, in all cases except one. Analyzing rating patterns sheds light on how physicians use and appreciate the profile.…”
Section: Discussioncontrasting
confidence: 75%
“…While many advocate for the utilization of opioid risk screening tools among patients at risk for aberrant behavior, these tools lack validity scales to ensure (or at least predict) the veracity of the responses. Furthermore, the intended purposes of these instruments are fairly transparent, and higher risk patients responding in a manner suggesting lower-than-actual risk has been documented 28. Although early studies of the COMM15,16,29 substantiated the validity of the measure through significant relationships with UDT results, both the current study and another 2019 investigation30 of HIV-positive patients taking opioids did not find a significant relationship.…”
Section: Discussioncontrasting
confidence: 45%
“…43,44 Chronic pain can lead to longterm opioid use in a subset of patients and can lead further to misuse and addiction. 43,44 The most common and simplest survey instruments for screening include the Screener and Opioid Assessment for Patients with Pain-revised, a 5-question tool, 45,46 and the Current Opioid Misuse Measure, a 17question scale. 47 Both measures can identify at-risk patients quickly, so appropriate referral or development of an opioid contract linked to monitoring and non-opioid treatment strategies can be implemented.…”
Section: Available Mental Health Screening and Assessment Toolsmentioning
confidence: 99%